Clinical Trial Update: Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution [Phase 2]

View source ↗

Summary

Phase 2 trial update showing nocturnal and diurnal intraocular pressure-lowering effects of netarsudil ophthalmic solution, with results posted in 2018, in ocul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• netarsudil ophthalmic solution (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2018-04-17